☆ 4.5 Letter

Immune checkpoint inhibitors as potential triggers for ANCA vasculitis

RMD OPEN (2022)

Related references

Note: Only part of the references are listed.

Review Urology & Nephrology

A Systematic Review of Immune Checkpoint Inhibitor-Associated Glomerular Disease

Abhijat Kitchlu et al.

Summary: This study summarized the association between immune checkpoint inhibitors and glomerular diseases, revealing various forms of diseases including pauci-immune glomerulonephritis, podocytopathies, and C3GN. Most patients experienced complete or partial recovery from acute kidney injury, but a portion of patients still required dialysis.

KIDNEY INTERNATIONAL REPORTS (2021)

Add to Collection

Article Medicine, General & Internal

Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis

Michael Walsh et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Add to Collection

Article Oncology

Anti-PD-1 Immunotherapy-Induced Flare of a Known Underlying Relapsing Vasculitis Mimicking Recurrent Cancer

Christopher S. Nabel et al.

ONCOLOGIST (2019)

Add to Collection

Article Oncology

Granulomatosis With Polyangiitis in a Patient on Programmed Death-1 Inhibitor for Advanced Non-small-cell Lung Cancer

Anne Sibille et al.

FRONTIERS IN ONCOLOGY (2019)

Add to Collection

Review Rheumatology

Vasculitis associated with immune checkpoint inhibitors-a systematic review

Anisha Daxini et al.

CLINICAL RHEUMATOLOGY (2018)

Add to Collection

Letter Rheumatology

Rapid granulomatosis with polyangiitis induced by immune checkpoint inhibition

Rob R. H. van den Brom et al.

RHEUMATOLOGY (2016)

Add to Collection

Article Rheumatology

Aberrant expression of the negative costimulator PD-1 on T cells in granulomatosis with polyangiitis

Benjamin Wilde et al.

RHEUMATOLOGY (2012)

Add to Collection

© Peeref 2019-2024. All rights reserved.